The iShares MSCI World ETF (URTH) trades just shy of its all-time high, but the calm is deceptive. Underneath a price of $194.16, volatility has surged above 76 percent. The fund’s immediate fate hinges on a handful of U.S. tech giants, with Microsoft and Apple set to report quarterly results on April 29 and 30, respectively. Their performance will test the ETF’s resilience in a challenging interest rate environment.
Microsoft’s report comes with its stock trading more than 30 percent below its record peak. While TD Cowen maintains a buy rating, it recently trimmed its price target to $540, citing tight GPU capacity. For its fiscal year, analysts project an adjusted earnings per share of $16.46, a 21 percent year-over-year increase. All eyes will be on whether its Azure cloud business can sustain its rapid growth. Apple, meanwhile, enters its earnings with unexpected momentum. The company recently posted a 20 percent jump in iPhone shipments to China, defying a 4 percent contraction in the broader Chinese smartphone market. Analysts now forecast solid revenue growth between 13 and 16 percent for its second quarter of 2026.
The concentration risk is stark. The technology sector commands 26.8 percent of the URTH portfolio, with the U.S. accounting for roughly 70 percent of its geographic allocation. Just three stocks—Nvidia (5.29%), Apple (4.55%), and Microsoft (3.17%)—combine for over 13 percent of the fund’s assets. This massive weighting exists within a vehicle that holds approximately 1,300 stocks across 23 developed countries.
Outside of tech, the financial sector has provided a sturdy foundation. As the fund’s second-largest segment at 16.17 percent, major banks have already delivered strong first-quarter 2026 results. JPMorgan Chase reported a record trading revenue of $11.6 billion, a 20 percent annual increase. Morgan Stanley significantly beat consensus estimates with earnings per share of $3.43, boosting its net profit by 29 percent to $5.57 billion.
Should investors sell immediately? Or is it worth buying MSCI World ETF?
In contrast, the healthcare sector, representing 9.45 percent of the portfolio, faces a looming threat. New U.S. tariffs on imported pharmaceutical goods are set to take effect at the end of July 2026. These will impose duties of at least 15 percent on products from the EU, Japan, South Korea, and Switzerland, with a 10 percent levy on British goods. The pressure on drugmaker margins has already prompted analysts at FactSet to trim their S&P 500 earnings growth forecast from 13.4 percent to 12.5 percent, partly due to downgrades in the health sector.
Despite stiff competition on fees, the $8.04 billion fund continues to attract capital, drawing roughly $531 million in net inflows last month alone. It charges a 0.24 percent expense ratio, which is higher than rivals like Invesco and UBS that offer comparable MSCI World ETFs for 0.05 and 0.06 percent. BlackRock defends its premium by pointing to a minimal tracking difference of just 0.02 percent and high liquidity—an argument that appears persuasive. The Royal Bank of Canada increased its stake in the fund by 17.5 percent in the fourth quarter of 2025, acquiring around two million shares.
Two structural events loom on the horizon. In May, MSCI will implement a methodological overhaul to its free-float calculation, which market observers expect to trigger significantly larger portfolio shifts than typical quarterly rebalancings. This could notably impact the weighting of mega-caps like Nvidia. Looking further ahead, a potential Nasdaq listing for SpaceX in June, with an estimated valuation of $1.75 trillion, could later increase the U.S. weight in the MSCI World index and drive substantial flows into tracking funds like the URTH.
For now, the immediate catalyst is clear. Disappointing results from the tech heavyweights could keep the ETF from reclaiming its 52-week high of $195.79, set on April 17. The next fixed date on the calendar is the ex-dividend notification on June 15.
Ad
MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from April 22 delivers the answer:
The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 22.
MSCI World ETF: Buy or sell? Read more here...
